Co-sponsored Morning Seminar

Co-sponsored Morning Seminar 1
Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics

Fri. May 24, 2024 8:15 AM - 9:15 AM Room 2 (Hall B7 (1))

Chair: Atsuo Nakagawa (St. Marianna University School of Medicine)

Co-sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.

[CMS1] Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics

*Atsuo Nakagawa¹, Craig Chepke^2,3,4 (1. Department of Neuropsychiatry, St. Marianna University School of Medicine, Kawasaki, Japan, 2. Excel Psychiatric Associates, Huntersville, North Carolina)

Co-sponsored Morning Seminar

Co-sponsored Morning Seminar 2
Future Brain Science Research in Japan

Sat. May 25, 2024 8:00 AM - 9:00 AM Room 3 (Hall D7)

Chair: Ryosuke Takahashi (Kyoto University), Tetsushi Kagawa (The Japan Agency for Medical Research and Development (AMED))

Co-sponsored by Japan Agencyfor Medical Researchand Development (AMED)

[CMS2] Future Brain Science Research in Japan - Perspective from the Core Organization of AMED Brain/MINDS 2.0

*Tomomi Shimogori¹ (1. RIKEN CBS)

Co-sponsored Morning Seminar

Co-sponsored Morning Seminar 3
Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease

Sun. May 26, 2024 8:15 AM - 9:15 AM Room 2 (Hall B7 (1))

Chair: Takeshi Iwatsubo (Department of Neuropathology, Graduate School of Medicine, The University of Tokyo National Institute of Neuroscience, National Center of Neurology and Psychiatry)

Co-sponsored by Eisai.co.,ltd. / BiogenJapan Ltd.

[CMS3] Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease

*Kenjiro Ono¹ (1. Department of Neurology, Kanazawa University Graduate School of Medical Sciences)

Sessions

Co-sponsored Symposium / Seminar » Co-sponsored Morning Seminar

Co-sponsored Morning Seminar 1
Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics

[CMS1] Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics

Co-sponsored Morning Seminar 2
Future Brain Science Research in Japan

[CMS2] Future Brain Science Research in Japan - Perspective from the Core Organization of AMED Brain/MINDS 2.0

Co-sponsored Morning Seminar 3
Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease

[CMS3] Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease

Authentication

Sessions

Co-sponsored Symposium / Seminar » Co-sponsored Morning Seminar

Co-sponsored Morning Seminar 1Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics

[CMS1] Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics

Co-sponsored Morning Seminar 2Future Brain Science Research in Japan

[CMS2] Future Brain Science Research in Japan - Perspective from the Core Organization of AMED Brain/MINDS 2.0

Co-sponsored Morning Seminar 3Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease

[CMS3] Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease

Authentication

Co-sponsored Morning Seminar 1
Understanding Neuroplasticity in the Treatment of Depression and the Potential Role of Digital Therapeutics

Co-sponsored Morning Seminar 2
Future Brain Science Research in Japan

Co-sponsored Morning Seminar 3
Reconsidering therapies based on amyloid pathogenesis of Alzheimer's disease